Hillary Clinton and Levaquin, A Teachable Moment
This is a good high profile opportunity for us to continue to warn the general public, family and friends about the dangers posed by the Fluoroquinolones.
Tagged: FDA
Fluoroquinolone Use In The Emergency Room: Go To The ER And Get “Floxed”
One hundred patients who went to the Emergency Room and received a Fluoroquinolone were studied, in ninety nine of those cases, errors were made with the Fluoroquinolone!
FDA Fails to Go The Distance, Yet Again
I am ecstatic about the new label changes. But given the FDA’s past track record, I will not happy until every medical professional, who has the ability to prescribe a FQ, is familiar with the label changes and safety precautions.
FDA Shell Game? I Hope Not
I think it was no coincidence that the FDA denied the mitochondrial citizen petition during the same time frame that they approved label changes. Right now the FDA is not acknowledging even the risk of mitochondrial toxicity.
FDA Changes Fluoroquinolone Label But Denies Citizen Petition on Mitochondrial Toxicity
On Thursday May 12, 2016 the FDA contacted those who have been pursuing label changes for the Fluoroquinolones and issued a public statement that the FDA is requiring label changes for antibacterial drugs called fluoroquinolones
Becoming a Danger to One’s Self and/or Others by Taking a Fluoroquinolone
It is very disturbing that an antibiotic, which is often given out for routine infections, may result in violence, anger toward others, and horribly, may result in suicide-related adverse events.
The Voices Heard Round The World – The November 5th FDA Meeting
On Nov. 5th, the true stars of our community took to the podium at the FDA to tell their personal stories. I, along with countless others, were humbled and honored. This meeting represented a huge step in the progress we are making to gain complete recognition of the travesty that the fluoroquinolone class of pharmaceuticals has wrought upon society, to achieve justice for those that have been damaged by these drugs, and to prevent future unnecessary pain and suffering not only for this generation, but for generations to come.
FDA To Hold Upcoming Meeting on Fluoroquinolones
We believe that the attention given the Fluoroquinolones through the combined media stories, past rallies, citizen petitions, in addition to community members meeting directly with FDA officials, provided some of the impetus, in part, for the scrutiny of the Fluoroquinolones being prescribed for these common health conditions.
Lessons From Ashley Madison
The Ashley Madison affair has led to extortion, divorces, ruined lives, lost jobs, and even suicides. But, let me let you in on another dirty little secret, one much worse than Ashley Madison…
Fluoroquinolone Community Goes to the FDA: Pediatrics and Rhabdomyolysis
On August 24th, 2015, members from the FQ community met with staff from the FDA in a third meeting to address the various FDA failures to adequately warn the general public about the true dangers FQ’s pose to the general public, especially our children.
Yet Another FDA Failure: PatientsLikeMe®
Why would the FDA make such an outrageous decision to enter into an unprecedented agreement to monitor post-marketing drug surveillance with a private company run by ex-pharmaceutical executives? The FDA would be better off looking at its FAERS data. If they did, they would see drug signals that they have ignored, especially for FQ’s.
Dr. Bennett’s PharmedOut Conference Presentation: A Synopsis
“The legal and Industry Guidance bars are not too high. The problem is that the FDA has failed to do its job regarding Fluoroquinolone antibiotic safety.”, Dr. Charles Bennett, PharmedOut 2015
Fluoroquinolone Community Goes to the FDA: The Pressure Continues
On June 10th, 2015 representatives from the Fluoroquinolone community met with Senate Staffers at the Dirksen Senate Building in Washington, D.C. to ensure pressure is maintained on the FDA in regards to updated warnings.
The Sad Truth of Pediatric Fluoroquinolone Usage
Sadly, the FDA review states that children experience the same Levaquin Adverse Events as adults. This means that the children have the possibility of experiencing adverse events that are consistent with mitochondrial toxicity.
Fluoroquinolone Community Goes to the FDA
We believe that our meeting, in addition to the extensive media attention, offers the best hope for action by the FDA on Fluoroquinolones to date.
Loading ...
